Results 111 to 120 of about 120,394 (280)

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

open access: yesArthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen   +14 more
wiley   +1 more source

Tissue Remodeling in Ocular Mucous Membrane Pemphigoid. [PDF]

open access: yesInvest Ophthalmol Vis Sci, 2023
Di Zazzo A   +9 more
europepmc   +1 more source

A Case of Mucous Membrane Pemphigoid in which VII Collagen was Suspected as an Autoantigen

open access: diamond, 2011
Chika Nanba   +12 more
openalex   +1 more source

Ortho-phthalaldehyde-induced skin mucous membrane damage from inadequate washing: Figure 1 [PDF]

open access: bronze, 2011
Masaru Horikiri   +4 more
openalex   +1 more source

Risk factors for relapse in ANCA‐associated vasculitis among patients with relapse after induction of remission with rituximab

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To determine risk factors for relapse of ANCA‐associated vasculitis (AAV) after re‐induction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post‐hoc analysis of the RITAZAREM clinical trial. Patients 15 years or older with AAV and a positive test for anti‐proteinase‐3 (PR3‐) or anti‐myeloperoxidase ...
Ellen Romich   +10 more
wiley   +1 more source

Nanostructured drug delivery systems for posterior segment eye diseases: Strategies to defy ocular barriers

open access: yesBMEMat, EarlyView.
Efficient drug delivery to the posterior segment of the eye has long been a challenging issue due to the complex ocular barriers. The review focuses on the promise held by nanoplatforms for barrier penetration and the key mechanisms involved, also highlighting their advantages in achieving efficient drug delivery and superior treatment of PSEDs ...
Yifan Shen   +7 more
wiley   +1 more source

CLINICAL RESULTS OF THE USAGE OF NEW LOCAL METHOD OF TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES OF ORAL MUCOUS MEMBRANE AND PARODONTIUM IN SMOKERS

open access: yesУкраїнський стоматологічний альманах, 2018
Treatment and prevention of inflammatory diseases of oral mucous membrane and parodontium for smokers are the most difficult problems in stomatology nowadays.
O. L. Zolotuhina   +4 more
doaj  

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

open access: yesBMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang   +12 more
wiley   +1 more source

Microtopography enhances intestinal drug absorption via Piezo1‐mediated tight junction modulation

open access: yesBMEMat, EarlyView.
Microtopography‐driven enhancement of oral peptide drug delivery by activating Piezo1 channels significantly improves paracellular permeability and bioavailability, offering a novel approach for optimizing macromolecule absorption in pharmaceutical formulations.
Yu Hu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy